Blog - HDL cholesterol

• 26 \ 11 \ 2018

  PCSK9 and its Inhibitors: A new approach in lipid lowering therapy

  

  Excellent biomarker for long term therapy.
  Biomarker of cardiovascular risk and atherosclerotic process.

  Read more